Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
sabatolimab
×
90 days
×
Clear all
Filters
3
NCT04150029
2026-01-13
STIMULUS-AML1
Novartis
Phase 2
Terminated
90 enrolled
26 charts